Identification of tumor-associated antigens in human thyroid papillar carcinoma

Biopolymers and Cell

Volumn 19, Issue 6, 2003, Pages 541-547

  Rodnin, N V ^a   Tykhonkova, I O ^a   Kyyamova, R G ^a   Garifulin, O M ^a   Gout, I T ^a,b   Filonenko, V V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861599124     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.000681     Document Type: Article

References (23)

1. Schmutzler C, Koehrle J. Innovative strategies for the treatment of thyroid cancer // Eur. J. Endocrinol.-2000.-143.-P. 15-24.
2. Shigenoby N., Nystrom E. Epidemiology and primary prevention of thyroid cancer // Thyroid.-2002.-12.-P. 889-896.
3. Parmiani G. Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripherial T cells // Immunol. Today.-1993.-14.-P. 536-538.
4. Old L. J., Chen Y. T. New paths in human cancer serology // J. Exp. Med.-1998.-187.-P. 1163-1167.
5. Jager D., Unkelbach M., Frei C, Bert F, Scanlan M. J., Jager E., Old L J., Chen Y. T., Knuth A. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/ testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum // Cancer Immunol.-2002.-N 28.-P. 2-5.
6. Behrends U., Schneider I., Rossler S., Frauenknecht H., Golbeck A., Lechner B., Eigenstetter G., Zobywalski C, Muller-Weihrich S., Graubner U., Schmid I., Sackerer D., Spath M., Goetz C, Prantl F., Asmuss H. P., Bise K., Mautner J. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries // Int. J. Cancer.-2003.-106, N 2.-P. 244-251.
7. Scanlan M. J., Jager D. Challenges to the development of antigen-specific breast cancer vaccines // Breast Cancer Res.-2001.-3, N 2.-P. 95-98.
8. Rodnin N. V., Tykhonkova I. O., Nemazany I. O., Gorlova L M., Komissarenko I. V., Palchevskiy S. S., Kuharenko O. P., Drobot L. B., Matsuka G. H., Filonenko V. V., Gout L T. Serological identification of autoimmune reactive antigens in human thyroid cancer cells // Exp. Oncol.-2000.-22, N 3.-P. 135-138.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction // Anal. Biochem.-1987.-162.-P. 156-159.
10. Rodnin M. V., Tykhonkova I. O., Filonenko V. V., Drobot L B., Matsuka G. H., Gout I. T. Search and characterization of melanoma antigens with the use of serological identification of antigens by recombinant expression cloning method // Biopolymers and Cell.-2000.-16.-P. 339-345.
11. Hajra JC M., Fearon E. R. Cadherin and Catenin alterations in human cancer // Genes, Chromosmes and Cancer.-2002.-34.-P. 255-268.
12. Aiken E. V., Wever O. D., Correia da Rocha A. S., Mareel M. Defective E-cadherin/catenin complexes in human cancer // Virchows Arch.-2001.-439.-P. 725-751.
13. Shiozaki H., Iihara K., Oka H., Kadowaki T., Matsui S., Gofuku J., Inoue M., Nagafuchi A., Tsukita S., Mori T. Immunohistochemical detection of alpha-catenin expression in human cancers // Amer. J. Pathol.-1994.-144, N 4.-P. 667-674.
14. Soda G., Antonaci A., Bosco D., Nardoni S., Metis M. Expression of bcl-2, c-erbB-2, p53, and p21 (wafl-cipl) protein in thyroid carcinomas // J. Exp. Clin. Cancer Res.-1999.-18, N 3.-P. 363-367.
15. Lee M. S., Igawa T., Yuan T. C, Zhang X. Q., Lin F. F, Lin M. F. ErbB-2 signalling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells // Oncogene.-2003.-22, N 5.-P. 781-796.
16. Stumptner C, Held H., Fuclisbichler A., Hauser H., Mischinger H. I., Zatlokal K., Denk H. Analysis of intracytoplasmic hyaline bodies in hepatocellular carcinoma // Amer. J. Pathol.-1999.-154, N 6.-P. 1701-1710.
17. Waghray A., Keppler D., Sloane B. F, Schuger L., Chen Y. Q. Analysis of a truncated form of cathepsin H in human prostate tumor cells // J. Biol. Chem.-2002.-277, N 13.-P. 11533-11538.
18. Tan S. T., Velickovic M., Ruger B. M., Davis P. F. Cellular and extracellular markers of hemangioma // Plast. Reconstr. Surg.-2000.-106, N 3.-P. 529-538.
19. Koroleva E. P., Lagarkova M. A., Mesheryakov A. A, Scanlan M. J., Old L. J., Nedospasov S. A., Kuprash D. V. Serological identification of antigens associated with renal cell carcinoma // Russ. J. Immunol.-2002.-7.-P. 3229-3238.
20. Uemura M., Nouso K, Kobayashi Y., Tanaka H., Nakamura S., Higashi T., Ono T., Nakayama E., Hanafusa T., Shiratori Y. Identification of the antigens predominantly reactive with serum from patients with hepatocellular carcinoma // Cancer.-2003.-97, N 10.-P. 2474-2479.
21. Moncrieff C. L., Bailey M. E., Morrison TV., Johnson K. J. Cloning and chromosomal localization of human Cdc42-binding protein kinase beta // Genomics.-1999.-57, N 2-P. 297-300.
22. Kaneko JC, Satoh K., Masamune A., Satoh A., Shimosegawa T. Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines // Pancreas.-2002.-24, N 1.-P. 34-41.
23. Rae F. JC, Hooper I. D., Nicol D. L., Clements J. A. Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors // Mol. Carcinog.-2001.-321.-P. 44-53.